Document Detail

Genotype combinations of plasminogen activator inhibitor-1 and angiotensin-converting enzyme genes and risk for early onset of coronary heart disease.
MedLine Citation:
PMID:  16926677     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Both angiotensin-converting enzyme genotype and plasminogen activator inhibitor type 1 genotype have an effect on fibrinolytic components and hence, may increase risk or advance occurrence of coronary heart disease. We examined the association of the angiotensin-converting enzyme and the plasminogen activator inhibitor type 1 genotypes, and their combinations, with early onset of coronary heart disease in a cohort of 907 patients with coronary heart disease. DESIGN AND METHODS: All patients with a coronary heart disease (International Classification of Diseases, 9th Rev. pos. 410-414), aged 30-70 years and participating in an inpatient rehabilitation program between January 1999 and May 2000 in two clinical centres in Germany were enrolled. The plasminogen activator inhibitor type 1 and the angiotensin-converting enzyme genotypes were determined by polymerase chain reaction, and the distribution was compared between patients with early (< or =55 years) and late (>55 years) onset of coronary heart disease. A multivariate analysis was employed to adjust for potentially confounding factors. RESULTS: Of the 907 included patients, 408 (45.0%) developed coronary heart disease before the age of 55 years. For the 4G/4G genotype of plasminogen activator inhibitor type 1 the odds ratio for early onset of coronary heart disease was 1.68 [95% confidence interval (CI) 1.01-2.57] and for the D/D genotype of angiotensin-converting enzyme the odds ratio was 1.22 (95% CI 0.84-1.76) after adjustment for covariates. In multivariate analysis an odds ratio of 3.10 (95% CI 1.51-6.36) was found for the association between the combined homozygosity for both polymorphisms (plasminogen activator inhibitor type 1 genotype 4G/4G and angiotensin-converting enzyme genotype D/D) and onset of coronary heart disease before the age of 55 years after controlling for sex, age, smoking, diabetes, hypertension, hyperlipidemia and school education. CONCLUSION: The co-existence of the 4G/5G polymorphism of the plasminogen activator inhibitor type 1 gene and the I/D polymorphism of the angiotensin-converting enzyme gene increases the risk for early onset of coronary heart disease in this population.
Michael Loew; Michael M Hoffmann; Harry Hahmann; Winfried Maerz; Hermann Brenner; Dietrich Rothenbacher
Related Documents :
7842197 - Rapid decline in fev1. a new risk factor for coronary heart disease mortality.
2338927 - Interstate differences in trends in coronary mortality and risk factors in australia.
10381497 - Prothrombotic genetic risk factors in young survivors of myocardial infarction.
11310937 - C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the p...
16932227 - Open lung ventilation does not increase right ventricular outflow impedance: an echo-do...
8734747 - Electrophysiological, rate dependent, and autonomic effects of the class iii antiarrhyt...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  13     ISSN:  1741-8267     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-08-23     Completed Date:  2006-09-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  449-56     Citation Subset:  IM    
Department of Epidemiology, German Centre for Research on Ageing, University of Heidelberg, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age of Onset
Coronary Disease / genetics*,  rehabilitation
Middle Aged
Multivariate Analysis
Odds Ratio
Peptidyl-Dipeptidase A / genetics*
Plasminogen Activator Inhibitor 1 / genetics*
Polymorphism, Genetic
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1; EC A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma lipids in a rural population of Bangladesh.
Next Document:  Actual clinical practice of exercise testing in consecutive patients after non-ST-elevation myocardi...